1182 related articles for article (PubMed ID: 19609863)
21. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.
Li Z; Yang S; Lin H; Huang J; Watkins PA; Moser AB; Desimone C; Song XY; Diehl AM
Hepatology; 2003 Feb; 37(2):343-50. PubMed ID: 12540784
[TBL] [Abstract][Full Text] [Related]
22. Effect of dietary fat to produce non-alcoholic fatty liver in the rat.
Ahmed U; Redgrave TG; Oates PS
J Gastroenterol Hepatol; 2009 Aug; 24(8):1463-71. PubMed ID: 19702912
[TBL] [Abstract][Full Text] [Related]
23. Antioxidant effect of apolipoprotein A-I on high-fat diet-induced non-alcoholic fatty liver disease in rabbits.
Wang W; Zhou W; Wang B; Zhu H; Ye L; Feng M
Acta Biochim Biophys Sin (Shanghai); 2013 Feb; 45(2):95-103. PubMed ID: 23174676
[TBL] [Abstract][Full Text] [Related]
24. Increased total scavenger capacity and decreased liver fat content in rats fed dehydroepiandrosterone and its sulphate on a high-fat diet.
Magyar Z; Bekesi G; Racz K; Feher J; Schaff Z; Lengyel G; Blazovics A; Illyes G; Szombath D; Hrabak A; Szekacs B; Gergics P; Marczell I; Dinya E; Rigo J; Tulassay Z
Gerontology; 2011; 57(4):343-9. PubMed ID: 20881377
[TBL] [Abstract][Full Text] [Related]
25. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model.
Burgueño AL; Gianotti TF; Mansilla NG; Pirola CJ; Sookoian S
Clin Sci (Lond); 2013 Jan; 124(1):53-63. PubMed ID: 22827449
[TBL] [Abstract][Full Text] [Related]
27. Hepatoprotective effects of Mimic of Manganese superoxide dismutase against carbon tetrachloride-induced hepatic injury.
Wang YH; Xu XJ; Li HL
Int Immunopharmacol; 2014 Sep; 22(1):126-32. PubMed ID: 24975834
[TBL] [Abstract][Full Text] [Related]
28. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
Jiang W; Guo MH; Hai X
World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
[TBL] [Abstract][Full Text] [Related]
29. Arginine reverses ethanol-induced inflammatory and fibrotic changes in liver despite continued ethanol administration.
Nanji AA; Jokelainen K; Lau GK; Rahemtulla A; Tipoe GL; Polavarapu R; Lalani EN
J Pharmacol Exp Ther; 2001 Dec; 299(3):832-9. PubMed ID: 11714866
[TBL] [Abstract][Full Text] [Related]
30. [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease].
Gao H; Xu L; Li D; Guang L; Deng W
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Nov; 33(11):1661-4. PubMed ID: 24273273
[TBL] [Abstract][Full Text] [Related]
31. Hepatoprotective effect of parthenolide in rat model of nonalcoholic fatty liver disease.
Bahabadi M; Mohammadalipour A; Karimi J; Sheikh N; Solgi G; Goudarzi F; Hashemnia M; Khodadadi I
Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):233-242. PubMed ID: 28555525
[TBL] [Abstract][Full Text] [Related]
32. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol inhibits nonalcoholic fatty liver disease in rats.
Bujanda L; Hijona E; Larzabal M; Beraza M; Aldazabal P; García-Urkia N; Sarasqueta C; Cosme A; Irastorza B; González A; Arenas JI
BMC Gastroenterol; 2008 Sep; 8():40. PubMed ID: 18782455
[TBL] [Abstract][Full Text] [Related]
34. Hepatic response to chronic hypoxia in experimental rat model through HIF-1 alpha, activator protein-1 and NF-kappa B.
Lau TY; Xiao J; Liong EC; Liao L; Leung TM; Nanji AA; Fung ML; Tipoe GL
Histol Histopathol; 2013 Apr; 28(4):463-71. PubMed ID: 23322610
[TBL] [Abstract][Full Text] [Related]
35. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration.
Nanji AA; Jokelainen K; Tipoe GL; Rahemtulla A; Dannenberg AJ
J Pharmacol Exp Ther; 2001 Nov; 299(2):638-44. PubMed ID: 11602676
[TBL] [Abstract][Full Text] [Related]
36. Tea polyphenols inhibit expressions of iNOS and TNF-alpha and prevent lipopolysaccharide-induced liver injury in rats.
Yuan GJ; Gong ZJ; Sun XM; Zheng SH; Li X
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):262-7. PubMed ID: 16698588
[TBL] [Abstract][Full Text] [Related]
37. Alterations in nuclear ploidy and cell phase distribution of rat liver cells in experimental alcoholic liver disease: relationship to antioxidant enzyme gene expression.
Fogt F; Nanji AA
Toxicol Appl Pharmacol; 1996 Jan; 136(1):87-93. PubMed ID: 8560485
[TBL] [Abstract][Full Text] [Related]
38. Melatonin Attenuates Inflammation, Oxidative Stress, and DNA Damage in Mice with Nonalcoholic Steatohepatitis Induced by a Methionine- and Choline-Deficient Diet.
Miguel FM; Picada JN; da Silva JB; Schemitt EG; Colares JR; Hartmann RM; Marroni CA; Marroni NP
Inflammation; 2022 Oct; 45(5):1968-1984. PubMed ID: 35419738
[TBL] [Abstract][Full Text] [Related]
39. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Jiang Y; Chen L; Wang H; Narisi B; Chen B
J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
[TBL] [Abstract][Full Text] [Related]
40. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury.
Yuan GJ; Zhou XR; Gong ZJ; Zhang P; Sun XM; Zheng SH
World J Gastroenterol; 2006 Apr; 12(15):2375-81. PubMed ID: 16688828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
